Regulation of vascular endothelial growth factor expression by estrogens and progestins

Environmental Health Perspectives

Volumn 108, Issue SUPPL. 5, 2000, Pages 785-790

  Hyder, Salman M ^a   Huang, Jaou Chen ^a   Nawaz, Zafar ^b   Boettger Tong, Holly ^b   Mäkelä, Sari ^c   Chiappetta, Connie ^a   Stancel, George M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Breast cancer; Endometrium; Estradiol; Estrogen; Fibroids; Leiomyomas; Progesterone; Progestin; Uterus; Vascular endothelial growth factor; VEGF

Indexed keywords

4 HYDROXYTAMOXIFEN; ANGIOGENESIS INHIBITOR; ANTIESTROGEN; ANTIGESTAGEN; ANTINEOPLASTIC AGENT; BASIC FIBROBLAST GROWTH FACTOR; CLOMIFENE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOHEXIMIDE; DACTINOMYCIN; DIETHYLSTILBESTROL; DIMETHYLBENZ[A]ANTHRACENE; ESTRADIOL; ESTROGEN DERIVATIVE; ETHINYLESTRADIOL; FIBROBLAST GROWTH FACTOR; FULVESTRANT; MESSENGER RNA; MIFEPRISTONE; NAFOXIDINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROGESTERONE DERIVATIVE; PROGESTERONE RECEPTOR; PROTEIN KINASE C; PUROMYCIN; RECEPTOR SUBUNIT; TAMOXIFEN; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER PREVENTION; CARCINOGENESIS; CELL CULTURE; CONTROLLED STUDY; DRUG TARGETING; ESTROGEN ACTIVITY; FEMALE; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; SYMPTOM; TRANSCRIPTION REGULATION; TUMOR GROWTH; TUMOR VASCULARIZATION; UTERUS BLEEDING; UTERUS MYOMA;

ANIMALIA; RODENTIA; VERTEBRATA;

EID: 0033670240     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.2307/3454307     Document Type: Article

References (51)

1. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
2. Vascular endothelial growth factor: Molecular and biological aspects
3. The biology of vascular endothelial growth factor
4. Vascular endothelial growth factor (VEGF) expression in human prostate cancer: In situ and in vitro expression of VEGF by human prostate cancer cells
5. Vascular endothelial growth factor (VEGF) and its receptors
6. Structure, expression, and receptor-binding properties of novel vascular endothelial growth factors
7. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signaling through VEGFR-2 (KDR) but not VEGFR-1 (Fit-1) receptor tyrosine kinases
8. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
9. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
10. Identification and localization of alternately spliced RNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines
11. Signal relays in the VEGF system
12. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis
13. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth
14. Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins
15. Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata
16. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor
17. Synthetic estrogen 17α-ethinyl estradiol induces pattern of uterine gene expression similar to endogenous estrogen 17β-estradiol
18. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen
19. Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780
20. The expression of vascular endothelial growth factor isoforms in cultured human endometrial stromal cells and its regulation by 17β-estradiol
21. Triphenylethylene antiestrogens induce vascular endothelial growth factor expression via their partial agonist activity
22. Detection of classical and atypical estrogen response elements in the untranslated regions of the rat VEGF gene
23. Induction of uterine VEGF mRNA by progestins and antiprogestins
24. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis
25. Validation of antivascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: Expression of VEGF in the human endometrium
26. Expression of mRNA for vascular endothelial growth factor transmembraneous receptors Fit1 and KDR, and the soluble receptor sflt in cycling human endometrium
27. Angiogenesis in cancer, vascular, rheumatoid and other diseases
28. Regulation of the expression of the VEGF/VPS and its receptors: Role in tumor angiogenesis
29. Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression
30. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer
31. Angiogenesis in endocrine-related cancer
32. Estrogen regulates vascular endothelial growth/permeability factor expression in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors
33. Progestin regulation of vascular endothelial growth factor in human breast cancer cells
34. Vascular endothelial growth factor are differentially regulated by steroid hormones and antiestrogens in breast cancer cells
35. Regulation of VEGF in the reproductive tract by sex-steroid hormones
36. Differential expression and selective localization of vascular permeability factor/vascular endothelial growth factor in the rat uterus during the estrous cycle
37. Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone-receptor ligands in vivo
38. Reciprocal paracrine interactions between tumor cells and endothelial cells: The 'angiogenesis progression' hypothesis
39. Heparin affinity: Purification of a tumor-derived capillary endothelial cell growth factor
40. Autoregulation of angiogenesis by cells of the vessel wall
41. Fibroblast growth factors as angiogenesis factors: New insights into their mechanism of action
42. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels
43. Vascular endothelial growth factor in human glioma cell lines: Induced secretion by EGF, PDGF-BB, and bFGF
44. Signal transduction by fibroblast growth factor receptors
45. Fibroblast growth factors and their receptors
46. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium
47. Differential expression of keratinocyte growth factor and its receptor in the human uterus
48. New concepts in the treatment of uterine leiomyomas
49. Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding